1921
Volume 95, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

Inexpensive, easy-to-use, and highly sensitive diagnostic tests are currently unavailable for typhoid fever. To identify candidate serodiagnostic markers, we have probed microarrays displaying the full serovar Typhi ( Typhi) proteome of 4,352 different proteins + lipopolysaccharides (LPSs), with sera from Nigerian pediatric typhoid and other febrile cases, Nigerian healthy controls, and healthy U.S. adults. Nigerian antibody profiles were broad (∼500 seropositive antigens) and mainly low level, with a small number of stronger “hits,” whereas the profile in U.S. adults was < 1/5 as broad, consistent with endemic exposure in Nigeria. Nigerian profiles were largely unaffected by clinical diagnosis, although the response against t1477 (hemolysin E) consistently emerged as stronger in typhoid cases. The response to LPS was also a strong discriminator of healthy controls and typhoid, although LPS did not discriminate between typhoid and nontyphoidal (NTS) disease. As a first step toward the development of a point-of-care diagnostic, t1477 and LPS were evaluated on immunostrips. Both provided good discrimination between healthy controls and typhoid/NTS disease. Such a test could provide a useful screen for salmonellosis (typhoid and NTS disease) in suspected pediatric cases that present with undefined febrile disease.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0869
2016-08-03
2017-09-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/95/2/431.html?itemId=/content/journals/10.4269/ajtmh.15-0869&mimeType=html&fmt=ahah

References

  1. Buckle GC, Walker CL, Black RE, , 2012. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J Glob Health 2: 010401.[Crossref]
  2. Andrews JR, Ryan ET, , 2015. Diagnostics for invasive Salmonella infections: current challenges and future directions. Vaccine 33 (Suppl 3): C8C15.[Crossref]
  3. Crump JA, Luby SP, Mintz ED, , 2004. The global burden of typhoid fever. Bull World Health Organ 82: 346353.
  4. Date KA, Bentsi-Enchill A, Marks F, Fox K, , 2015. Typhoid fever vaccination strategies. Vaccine 33 (Suppl 3): C55C61.[Crossref]
  5. MacLennan CA, Martin LB, Micoli F, , 2014. Vaccines against invasive Salmonella disease: current status and future directions. Hum Vaccin Immunother 10: 14781493.[Crossref]
  6. Khan MI, Soofi SB, Ochiai RL, Habib MA, Sahito SM, Nizami SQ, Acosta CJ, Clemens JD, Bhutta ZA, DOMI Typhoid Karachi Vi Effectiveness Study Group; , 2012. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan. Vaccine 30: 53895395.[Crossref]
  7. Obaro SK, Hassan-Hanga F, Olateju EK, Umoru D, Lawson L, Olanipekun G, Ibrahim S, Munir H, Ihesiolor G, Maduekwe A, Ohiaeri C, Adetola A, Shetima D, Jibir BW, Nakaura H, Kocmich N, Ajose T, Idiong D, Masokano K, Ifabiyi A, Ihebuzor N, Chen B, Meza J, Akindele A, Rezac-Elgohary A, Olaosebikan R, Suwaid S, Gambo M, Alter R, Davies HD, Fey PD, , 2015. Salmonella bacteremia among children in central and northwest Nigeria, 2008–2015. Clin Infect Dis 61 (Suppl 4): S325S331.[Crossref]
  8. Obaro S, Lawson L, Essen U, Ibrahim K, Brooks K, Otuneye A, Shetima D, Ahmed P, Ajose T, Olugbile M, Idiong D, Ogundeji D, Ochigbo C, Olanipekun G, Khalife W, Adegbola R, , 2011. Community acquired bacteremia in young children from central Nigeria: a pilot study. BMC Infect Dis 11: 137.[Crossref]
  9. Lee SJ, Liang L, Juarez S, Nanton MR, Gondwe EN, Msefula CL, Kayala MA, Necchi F, Heath JN, Hart P, Tsolis RM, Heyderman RS, MacLennan CA, Felgner PL, Davies DH, McSorley SJ, , 2012. Identification of a common immune signature in murine and human systemic salmonellosis. Proc Natl Acad Sci USA 109: 49985003.[Crossref]
  10. Liang L, Juarez S, Nga TV, Dunstan S, Nakajima-Sasaki R, Davies DH, McSorley S, Baker S, Felgner PL, , 2013. Immune profiling with a Salmonella typhi antigen microarray identifies new diagnostic biomarkers of human typhoid. Sci Rep 3: 1043.
  11. Waddington CS, Darton TC, Jones C, Haworth K, Peters A, John T, Thompson BA, Kerridge SA, Kingsley RA, Zhou L, Holt KE, Yu LM, Lockhart S, Farrar JJ, Sztein MB, Dougan G, Angus B, Levine MM, Pollard AJ, , 2014. An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella typhi challenge delivered in sodium bicarbonate solution. Clin Infect Dis 58: 12301240.[Crossref]
  12. Benjamini Y, Hochberg Y, , 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57: 289300.
  13. Crump JA, Mintz ED, , 2010. Global trends in typhoid and paratyphoid fever. Clin Infect Dis 50: 241246.[Crossref]
  14. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA, 3rd Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De León FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA, , 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 20952128.[Crossref]
  15. Iperepolu OH, Entonu PE, Agwale SM, , 2008. A review of the disease burden, impact and prevention of typhoid fever in Nigeria. West Afr J Med 27: 127133.
  16. Akinyemi KO, Oshundare YO, Oyeyinka OG, Coker AO, , 2012. A retrospective study of community-acquired Salmonella infections in patients attending public hospitals in Lagos, Nigeria. J Infect Dev Ctries 6: 387395.[Crossref]
  17. Olopoenia LA, King AL, , 2000. Widal agglutination test—100 years later: still plagued by controversy. Postgrad Med J 76: 8084.[Crossref]
  18. Charles RC, Liang L, Khanam F, Sayeed MA, Hung C, Leung DT, Baker S, Ludwig A, Harris JB, Larocque RC, Calderwood SB, Qadri F, Felgner PL, Ryan ET, , 2014. Immunoproteomic analysis of antibody in lymphocyte supernatant in patients with typhoid fever in Bangladesh. Clin Vaccine Immunol 21: 280285.[Crossref]
  19. Herath HM, , 2003. Early diagnosis of typhoid fever by the detection of salivary IgA. J Clin Pathol 56: 694698.[Crossref]
  20. Nardiello S, Pizzella T, Russo M, Galanti B, , 1984. Serodiagnosis of typhoid fever by enzyme-linked immunosorbent assay determination of anti-Salmonella typhi lipopolysaccharide antibodies. J Clin Microbiol 20: 718721.
  21. Zaka-ur-Rab Z, Abqari S, Shahab T, Islam N, Shukla I, , 2012. Evaluation of salivary anti-Salmonella typhi lipopolysaccharide IgA ELISA for serodiagnosis of typhoid fever in children. Arch Dis Child 97: 236238.[Crossref]
  22. Lafleur L, Stevens D, McKenzie K, Ramachandran S, Spicar-Mihalic P, Singhal M, Arjyal A, Osborn J, Kauffman P, Yager P, Lutz B, , 2012. Progress toward multiplexed sample-to-result detection in low resource settings using microfluidic immunoassay cards. Lab Chip 12: 11191127.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0869
Loading
/content/journals/10.4269/ajtmh.15-0869
Loading

Data & Media loading...

  • Received : 01 Dec 2015
  • Accepted : 04 Apr 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error